The UK government has announced the establishment of the AI Biosecurity Lab (AIBL), the world's first dedicated organisation focused on applying advanced artificial intelligence to combat biological threats. The project forms part of the National AI Biosecurity Initiative and builds on the country's broader biological security strategy.
The initiative is backed by £100m in state investment, alongside up to £200m in commitments from leading artificial intelligence companies. The government plans to secure funding by combining public and philanthropic resources, while the laboratory's operational strategy is based on partnerships with the public sector, academic institutions and industry stakeholders.
The new laboratory's mission is to connect artificial intelligence and biological science experts, with the aim of developing technical capabilities to detect, prevent and respond to biological threats. Initial activities are focused on improving the early detection of new biological threats and accelerating the development, testing and deployment of vaccines and other medical countermeasures.
AIBL plans to support UK national biosecurity centres and industry, enabling a faster response to disease outbreaks in the UK and around the world. OpenAI, Anthropic, Basecamp Research and Google DeepMind will participate in the laboratory's work.
OpenAI will provide £100m in the form of compute credits (tokens) and access to its most capable models through the Rosalind Biodefense programme. Anthropic is providing up to £100m through credits, secure model access and dedicated technical support.
Google DeepMind and UK firm Basecamp Research will participate in research projects and the development of AI tools for science. Basecamp Research will provide access to its AI biology models and technical expertise, while Google DeepMind scientists and experts will collaborate on research and provide access to Gemini models and specialised scientific models.
